Lingke
X

 

      +86 0571-87711179

ychen1@lynkpharma.com

Lynk Pharmaceuticals Co., Ltd.    |   浙ICP备19010130号-2   |   Powered by www.300.cn    |   Manager 

CONTACT US

website

Search

291 Fucheng Road, Bldg 5-402, Jianggan, Hangzhou,
Zhejiang 310018, China

>
>
Lynk Pharmaceuticals enters exclusive licensing agreements develop RAS inhibitors with a novel MOA

Lynk Pharmaceuticals enters exclusive licensing agreements develop RAS inhibitors with a novel MOA

Page view
[Abstract]:
HANGZHOU, China, July 27, 2020 /PRNewswire/ -- Lynk Pharmaceuticals is pleased to announce exclusive licensing agreements with Kobe 
University and RIKEN Research Institute to develop RAS inhibitors with a novel MOA.